Based on current clinical research, tesofensine does not cause weight gain; it causes significant weight loss. Here's a breakdown of the evidence and why confusion might arise:
1.Primary Mechanism & Effect: Tesofensine is a triple monoamine reuptake inhibitor (serotonin, noradrenaline, dopamine). Its primary effect in obesity studies is appetite suppression, leading to reduced calorie intake and subsequent weight loss.
2.Clinical Trial Evidence:
○The landmark phase 2 trial published in The Lancet (2008) demonstrated dose-dependent weight loss in obese individuals over 24 weeks. Participants lost significantly more weight than those on placebo:
◇0.25 mg dose: ~6.7% weight loss
◇0.5 mg dose: ~11.3% weight loss
◇1.0 mg dose: ~12.8% weight loss
◇Placebo: ~2.2% weight loss
○Subsequent studies have consistently replicated these findings, showing tesofensine leads to greater weight loss compared to placebo.
3.Why the Question Might Arise? Confusion & Nuances:
○Weight Regain After Stopping: Like most anti-obesity medications, weight lost while taking tesofensine is often regained after discontinuation if healthy habits aren't maintained. Someone might misinterpret this regain as the drug "causing" gain, but it's actually the loss of the drug's effect.
○Tolerance/Reduced Efficacy: While long-term data is limited, it's possible the weight loss effect could plateau or lessen over time for some individuals, potentially leading to some regain while still on the drug, though this wouldn't typically result in net gain compared to starting weight.
○Individual Variability: As with any drug, individual responses vary. It's theoretically possible for someone to have an atypical response, but weight gain has not been a reported side effect in trials.
○Side Effects vs. Weight Gain: Common side effects include dry mouth, nausea, insomnia, increased heart rate, and diarrhea. None of these are directly linked to causing weight gain. Fluid retention isn't a typical reported side effect either.
○Misinformation: Less reliable sources might conflate it with other medications or misunderstand its mechanism.
In Summary:
●Tesofensine is under investigation specifically for weight loss.
●Robust clinical trial data shows it causes significant weight loss, not weight gain.
●Weight regain is likely after stopping the medication, which is a common challenge with obesity pharmacotherapy, not a direct effect of the drug causing gain.
●Weight gain has not been reported as a side effect in clinical studies.
Important Note: Tesofensine is not yet approved for weight loss by major regulatory bodies like the FDA or EMA. It remains under investigation. Always consult a healthcare professional for advice on weight management medications and their potential effects. They can provide guidance based on your individual health profile and the latest approved treatments.
https://www.hormonerawsource.com/steroid-finished/steroid-finished-tablets/stromusc-tesofensine-plus-500mcg-for.html
